Chen Wan-Shan 4
4 · BELITE BIO, INC · Filed Apr 13, 2026
Research Summary
AI-generated summary of this filing
Belite Bio (BLTE) Director Chen Wan-Shan Sells 1,100 Shares
What Happened
- Chen Wan-Shan, a director of Belite Bio, sold 1,100 American depositary shares (ADS) on April 9, 2026, at $180.43 per ADS for proceeds of $198,473. The transaction is reported as a sale (Form 4 code S) and was effected as an open-market or private sale.
Key Details
- Transaction date and price: 2026-04-09 — 1,100 ADS @ $180.43 each.
- Total proceeds: $198,473.
- Shares owned after the transaction: Not specified in the provided filing.
- Footnotes: Each ADS represents one ordinary share (F1). The sale was made pursuant to a Rule 10b5-1 trading plan adopted 12/23/2025 (F2).
- Filing timeliness: Report filed 2026-04-13, which is within the standard two business-day reporting window for a 4/9 trade (timely).
Context
- The sale was executed under a pre-arranged 10b5-1 plan, which typically schedules trades in advance and can indicate routine disposition rather than a new, discretionary view on the company. Sales do not necessarily signal negative insider sentiment; purchases are generally more informative for signaling.
Insider Transaction Report
Form 4
BELITE BIO, INCBLTE
Chen Wan-Shan
Director
Transactions
- Sale
American depositary share
[F1][F2]2026-04-09$180.43/sh−1,100$198,473→ 9,096 total
Footnotes (2)
- [F1]Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/23/2025.
Signature
/s/ Wan-Shan Chen|2026-04-13